TASS/. The Health Insurance Administration of South China's Hainan Province has temporarily included the country's oral anti-Covid drug Azvudine into the list of medicine covered by medical insurance.

Mainland media noted that Pfizer’s Paxlovid has been approved in China, along with Genuine Biotech’s Azvudine. Zhejiang Huahai Pharmaceutical (600521 CH) will make the drug for Pfizer.